Brad Wilson (investor - Angel Investor)

United States
See something wrong or missing? Let us know
Offices:Philadelphia

Brad Wilson works for GlaxoSmithKline in USA

Average round investment:1.76M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: United Kingdom OxCan
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Brad Wilson

Name Criteria
United States Mayfield Fund
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Germany Gröger Management
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Damien Lane
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Bruce Berkeley
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Portugal Alter Ventures
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Michael Polansky
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Robert Fenton
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom James Dacombe
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Conduit Connect
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Beresford Ventures
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Top